Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Non-Current Liabilities (2021 - 2025)

Historic Total Non-Current Liabilities for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $2.1 billion.

  • Core Scientific's Total Non-Current Liabilities rose 23022.59% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 23022.59%. This contributed to the annual value of $1.3 billion for FY2024, which is 925.37% up from last year.
  • As of Q3 2025, Core Scientific's Total Non-Current Liabilities stood at $2.1 billion, which was up 23022.59% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Total Non-Current Liabilities ranged from a high of $2.1 billion in Q3 2025 and a low of $12.9 million during Q1 2021
  • For the 5-year period, Core Scientific's Total Non-Current Liabilities averaged around $883.7 million, with its median value being $1.0 billion (2023).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first surged by 1170910.13% in 2022, then crashed by 8655.04% in 2023.
  • Over the past 5 years, Core Scientific's Total Non-Current Liabilities (Quarter) stood at $1.0 billion in 2021, then plummeted by 81.66% to $189.7 million in 2022, then surged by 537.66% to $1.2 billion in 2023, then grew by 9.25% to $1.3 billion in 2024, then skyrocketed by 58.39% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.4 billion during Q1 2025.